Protective Effects of PPARγ on Renal Ischemia-Reperfusion Injury by Regulating miR-21

Renal ischemia-reperfusion injury (RIRI) is a common pathological process that causes kidney injury. Previous studies have indicated that both peroxisome proliferator-activated receptor γ (PPARγ) and microRNA-21 (miR-21) exert protective effects against RIRI. However, their relationship is not well understood. In the present study, we investigated the role of the PPARγ/miR-21/programmed cell death 4 (PDCD4) axis in IRI, both in vivo and in vitro. In vitro cell hypoxia/reoxygenation (H/R) and in vivo RIRI models were established, and cell viability, cell apoptosis, and key molecule expression profiles were analyzed. Our results showed that both PPARγ and miR-21 had protective effects against RIRI to varying degrees, and there was an interaction between PPARγ and miR-21. PPARγ could promote the expression of miR-21 and partially protect against RIRI by reducing the level of the miR-21 target protein (PDCD4). Our findings underscore the potential utility of future clinical investigations of PPARγ activation and targeting of the underlying miR-21/PDCD4/caspase-3 pathway, which may participate in the pathogenesis of human IRI.


Introduction
Renal ischemia-reperfusion injury (RIRI) is a relatively common pathological process that causes kidney injury and severe complications such as acute renal failure. Complicated molecular mechanisms, including the accumulation of reactive oxygen species (ROS), apoptosis, and inflammatory cell infiltration, are reported to be pivotal in the process of RIRI [1,2]. However, elaborating the exact mechanisms of RIRI is difficult, which makes RIRI a challenge during clinical therapy.
Activation of peroxisome proliferator-activated receptor γ (PPARγ) is important in protecting organs from IRI [3]. As kidneys have an abundant blood supply, they are sensitive to ischemia, and even transient ischemia caused by various reasons may induce severe renal reperfusion injury.
RIRI is associated with high morbidity and mortality. We previously demonstrated that the PPARγ synthetic ligand pioglitazone exerts its renoprotective functions by inhibiting apoptosis, alleviating oxidative stress, and enhancing autophagy in in vitro and in vivo models [4][5][6]. Moreover, it seems that RIRI-induced inflammatory and oxidative responses are potentially ameliorated by administering pioglitazone, with inhibition of the NF-κB signaling pathway, and alleviated renal insults in rats [7]. The crucial roles of modulating NF-κB signaling pathway-mediated inflammation and oxidative stress in IRI have also been demonstrated by other researchers [8,9], which may provide a theoretical basis for the exploration of novel targets and pathways in RIRI therapy. In this study, we further investigated the underlying molecular mechanisms of the nuclear transcription factor PPARγ in RIRI.
As an important member of the microRNA family, microRNA-21 (miR-21) has been studied as a tumorrelated gene in previous studies. Recent studies on miRNA-21 have shown that it is also closely associated with the pathological process of IRI. Since Godwin et al. identified the miRNA signature of RIRI [10], substantial efforts have been made to understand the relationship between miRNAs and organ IRI amelioration. The protective effects of miR- 21 in RIRI have been demonstrated in our previous studies, and the levels of blood urea nitrogen (BUN) and creatinine in the miR-21 overexpression group were lower than those in the corresponding control group [11]. We explored the effects of miR-21 and PPARγ as well as the crosstalk between miR-21 and PPARγ. 2.2. Cell Transfection. PPARγ overexpression (OE) plasmid or shRNA (Hanbio, Shanghai, China) was transfected to regulate PPARγ expression. miR-21 mimic and inhibitor (Hanbio, Shanghai, China) were transfected to regulate miR-21 expression. For cell transfection, Lipo3000 transfection reagent (Invitrogen, Carlsbad, CA, USA) was used, according to the manufacturer's instructions.

H/R Protocol.
The cells were cultured to the logarithmic phase, and the H/R protocol was performed as follows. The hypoxic condition was realized in a constant temperature three-gas cell incubator, and the incubator was subjected to 95% N 2 and 5% CO 2 for 4 h. For reoxygenation, the culture medium of hypoxic cells was replaced, and the cells were returned to the normoxic culture chamber at 37°C under 5% CO 2 conditions for 12 h.

Cell Counting Kit-8 (CCK-8) Assay.
To investigate cell viability, a CCK-8 (US Everbright Inc., China) assay was performed. Cells were seeded at a density of 8000 cells/well into 96-well plates before the assay was performed. The reagent (10 μL) was added after incubation at 37°C for 2 h, and a microplate reader was added; the absorbance was measured at a wavelength of 450 nm (A450).

Determination of Tumor Necrosis Factor-α (TNF-α) and
Lactate Dehydrogenase (LDH) Levels. The cell culture medium was collected for each group. LDH commercial kit reagents (Solarbio, Beijing, China) were used for determination. All experimental procedures were performed in accordance with the manufacturer's instructions. TNF-α levels were detected using an enzyme-linked immunosorbent assay (ELISA) kit (Boster, Wuhan, China) according to the manufacturer's instructions.
2.6. Flow Cytometric Analysis. Cells were washed twice with PBS, harvested with trypsin solution without EDTA, collected, and centrifuged at 1,000 rpm for 5 min. The apoptosis rate was detected for the resulting cells. All procedures were based on FITC-Annexin V and PI Apoptosis Kit (US Everbright Inc., China). After mixing with 300 μL of prechilled 1x binding buffer for each tube, further detection was realized using a flow cytometer.
2.7. Dual-Luciferase Reporter Assay. To confirm the relationship between miR-21 and the target genes, the synthesized wild-type (wt) and mutant (mu) luciferase reporter plasmids (Hanbio, Shanghai, China) were used for luciferase reporter assays. The prepared NRK-52E cells were seeded in a sixwell plate, and after the cells reached 80% confluence, cotransfections of wt-PDCD4 or mu-PDCD4 plasmids and miR-21 mimics or miR-21 negative controls were performed using Lipofectamine 3000 (Thermo Fisher, USA). Six hours later, the culture medium was replaced, and 48 h after transfection, the cells were collected for detection. Dual-luciferase activity was detected using a commercial Dual-Luciferase Reporter Assay Kit (TransGen Biotech, Beijing, China) according to the manufacturer's instructions.
2.10. Animal Procedures. Pathogen-free male C57BL/6 mice (8-10 weeks old, weighing 18-20 g) were obtained from the Laboratory Animal Center of Nanchang University (Nanchang, Jiangxi, China). This study was assessed and approved by the Ethics Committee for Animal Experiments of the Second Affiliated Hospital of Nanchang University. For renal transfection, the designed overexpression PPARγ recombinant adeno-associated virus (AAV9) (Hanbio, Shanghai, China) was injected directly into the kidneys. Preoperative fasting was performed for 8-12 h before surgery, and the rats were anesthetized intraperitoneally by administering pentobarbital sodium (50 mg/kg). When fully anesthetized, the left kidney was exposed via a 1.5-2 cm incision along the median abdominal line, and vehicles were injected into three to four sites with recombinant AAV [12]. Four weeks after the injection, antagomiR-21 and premiR-21 (RiboBio, Guangzhou, China) were used for miR-21 regulation. AntagomiR-21 and premiR-21 were injected via tail veins into the mice for 3 consecutive days. The mice were sacrificed for kidney isolation, quickly frozen in liquid nitrogen, and stored at -80°C for further analysis. The PPARγ-AAV9 transfection efficiency and miR-21 expression levels were measured.
2.11. Mouse Model of RIRI. Mice were abstained for 8-12 h before the construction of the RIRI model. The mice were anesthetized by intraperitoneal administration of pentobarbital sodium (50 mg/kg). Following a 1.5-2 cm incision along the median abdominal line, the renal pedicles were bluntly dissected, and RIRI was induced by bilateral clamping of the renal arteries. Once the color of the kidneys turned into a paler shade, occlusion was verified. After the kidneys were subjected to pedicle occlusion for 45 min, the microvascular clamps were removed from the pedicles, and the reperfusion stage was immediately implemented. Mice were sacrificed for further analysis 24 h after reperfusion.
2.12. Assessment of Renal Function. Blood samples were collected from the orbital vein of the mice into centrifuge tubes 24 h after reperfusion. Serum was obtained by centrifuging the blood samples at 3,000 rpm for 10 min. Serum creatinine (Scr) and blood urea nitrogen (BUN) levels were examined according to the manufacturer's instructions to assess renal function, and commercial detection kits were obtained from the Nanjing Jiancheng Bioengineering Institute (Nanjing, China).
2.13. Histopathologic Evaluation of Kidney. The kidneys of euthanized mice in different groups were collected 24 h after reperfusion. For histopathological examination, the kidneys were dissected coronally and fixed using a paraformaldehyde tissue fixator, embedded in paraffin, and sliced into 4 mm sections for hematoxylin and eosin (H&E) staining. Morphological changes in renal tissue were observed using an optical microscope. The degree of renal tubular necrosis was assessed according to the method described by Zou et al. [7]. A maximum score of 4 indicates the highest degree of necrosis, 0 = normal kidney; 1 = minimal necrosis, <5% necrotic renal tubular involvement; 2 = mild necrosis, 5%-25% involvement; 3 = moderate necrosis, 25%-75% involvement; and 4 = severe, >75% involvement.
2.14. Immunohistochemical (IHC) Analysis. An IHC assay was used to examine PPARγ and PDCD4 expression in the kidneys. The sacrificed kidney tissues were embedded in paraffin and cut into 4 μm thick sections. The samples were deparaffinised with xylene and rehydrated with pure ethanol. BSA (3%) was added to the circle to evenly cover the tissue sections, which were then sealed for 60 min at room temperature. The sealing solution was gently removed, and the PPARγ (Cell Signalling Technology; USA) and PDCD4 (Cell Signalling Technology; USA) primary antibodies were used at a dilution of 1 : 200 for incubation overnight at 4°C. The sections were placed in PBS and washed by shaking on a decolorizing shaker thrice for 5 min each. After the sections were shaken slightly and dried, the tissues were covered with HRP-labeled secondary antibodies. After incubation with DAB and counterstaining with hematoxylin, the images were collected using light microscopy.
2.15. Immunofluorescence Analysis. Kidney tissues were embedded in paraffin and cut into 4 μm slides. The samples were deparaffinised with xylene and rehydrated with pure ethanol. Blocking was performed with 5% bovine serum albumin for 2 h at room temperature. The sealing solution was gently removed; slides were incubated with the PPARγ primary antibodies (1 : 200; Cell Signalling Technology; USA) and PDCD4 (1 : 600; Cell Signalling Technology; USA) primary antibody overnight at 4°C. The slides were washed three times with PBS, and then, the objective tissue was covered with a secondary antibody and incubated at room temperature for 60 min in the dark. After incubation with the DAPI solution at room temperature for 20 min in the dark, images were acquired using a fluorescence microscope.
2.16. TUNEL Assay. The terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling assay (TUNEL) was used for examining cell apoptosis. The sacrificed kidney tissues were embedded in paraffin and cut into 4 μm thick sections. The samples were deparaffinised with xylene and rehydrated with pure ethanol. A 0.5% Triton-X-100 working solution was used for permeabilization, incubated at room temperature for 20 min, and washed thrice with PBS. The TUNEL reaction was performed according to the instructions of the TUNEL Detection Kit (Servicebio, Wuhan, China). After incubation with the DAPI solution at room temperature for 10 min, images were collected using a fluorescence microscope.
2.17. Statistical Analysis. All data were statistically analyzed using the GraphPad Prism software (version 8.0). Quantitative data were expressed as mean ðxÞ ± S:E: Differences between two groups were compared using the t-test, and  Oxidative Medicine and Cellular Longevity multiple groups were compared using one-way ANOVA along with Tukey's post hoc multiple-comparisons test. p < 0:05 was considered statistically significant.

Results
3.1. PPARγ and miR-21 Improved Cell Viability after the H/R Procedure. A CCK8 assay was performed to evaluate the viability of each group. As shown in Figure 1, cells subjected to H/R showed significantly decreased cell viability compared with the negative control (NC) group. However, cell viability in cells subjected to H/R was significantly improved when PPARγ and miR-21 were upregulated as compared to that in the H/R alone group. Interestingly, when both PPARγ and miR-21 were upregulated simultaneously in the NRK-52E cells, cell viability was significantly improved compared to that in the H/R group. miR-21 may have little effect on cytoprotection under conditions of low PPARγ expression.

5
Oxidative Medicine and Cellular Longevity +HR group. These results suggest that PPARγ and miR-21 could attenuate cell apoptosis, indicating the pivotal role of PPARγ in cytoprotection.

PPARγ Could
Upregulate the miR-21 Levels. As the transcription factor PPARγ is involved in different stages of miRNA biogenesis, its protective effects during H/R injury may be due to the underlying cross-talk between PPARγ and miR-21. To identify the mechanism of PPARγ and miR-21 regulation during H/R, we examined gene expression using qPCR (Figure 4(a)). In the H/R group, both PPARγ and miR-21 expression decreased, and the applica-tion of miR-21 mimic and inhibitor effectively regulated miR-21 expression, indicating that transfection was efficient. Furthermore, the miR-21 level in the PPARγ overexpression group was higher than that in the NC group, and the miR-21 level was decreased by silencing PPARγ expression, whereas it seems that activation of miR-21 was unable to affect PPARγ mRNA expression. However, no significant difference was observed between the miR-21 mimic and inhibitor groups. These results demonstrate that the transcription factor PPARγ could upregulate miR-21 levels. In addition, the cytoprotection of PPARγ may be partially mediated by the upregulation of miR-21 levels.

Oxidative Medicine and Cellular Longevity
To examine the molecular mechanism of PPARγ-mediated protection of cells against H/R injury, a dual-luciferase reporter assay was performed. It was observed that the miR-21 downregulated promoter activity of PDCD4 by directly targeting 3 ′ -UTR. In other words, the cytoprotection effect of PPARγ on cell H/R injury may partially regulate the miR-21 expression and thus downregulated its target PDCD4 (Figure 4(b)).

PPARγ Alleviates H/R Injury by Downregulating
Caspase-3 and PDCD4 Levels. In the caspase-dependent apoptosis pathway, caspase-3 is the key molecule that stimulates cell apoptosis. PDCD4 is also regarded as a preapoptotic gene. To ascertain the role of PPARγ and miR-21 in H/R injury, we examined the expressions of PPARγ, caspase-3, and PDCD4 using western blotting. We found that H/R induced downregulation of PPARγ proteins, and no significant difference was noted between the miR-21 mimic and inhibitor groups (data not shown). The expression of cleaved caspase-3 and PDCD4 was significantly higher in cells subjected to H/R injury than in the NC group. The overexpression of PPARγ partially reversed their expression, and cleaved caspase-3 and PDCD4 were increased when PPARγ expression was   Figure 1). Additionally, miR-21 expression is related to the expression of cleaved caspase-3 and PDCD4. Upregulated miR-21 expression in the mimic group was accompanied by a decrease in PDCD4 expression, which was blocked by the miR-21 inhibitor (Supplementary Figure 2). In the mimic+HR group, the expression of cleaved caspase-3 and PDCD4 was significantly reduced compared with that in the HR group. When we cotransfected the overexpression PPARγ plasmid and miR-21 mimic, H/R-induced cleaved caspase-3 and PDCD4 expression was significantly ameliorated compared to the OE-PPARγ+HR or miR-21 mimic+HR groups ( Figure 5).

PPARγ and miR-21 Improved Kidney Damage in Mice
Subjected to I/R Injury. A RIRI model was established to investigate the effects of PPARγ and miR-21 on renal tissues. H&E staining was used to evaluate renoprotective effects (Figures 6(a) and 6(b)). IRI resulted in severe histopathological damage in the renal tissue, and serious tubular dilatation, congestion, edema, vacuolization, and tubular necrosis were noted in the IRI group. However, pretreatment    Scr and BUN levels were used to assess renal function. Collectively, PPARγ and miR-21 could effectively protect the kidney against IRI, and Scr and BUN levels were significantly alleviated in the AAV9-PPARγ+IRI and premiR-21 +IRI groups. It is worth noting that despite both PPARγ and miR-21 having renoprotective functions, the AAV9-PPARγ+IRI group had lower Scr and BUN levels than the premiR-21+IRI group, suggesting that PPARγ-mediated miR-21 upregulation was involved in renoprotective effects (Figures 6(c) and 6(d)).

PPARγ and miR-21
Decreased Apoptotic Cell Death in the Kidney Tissue. Groups that underwent IRI had significantly higher apoptosis rates than those in the non-IRI groups. No significant difference in apoptotic cells was observed between the PBS+sham and other sham groups. In comparison with the IRI group, the apoptosis rates in the AAV9-PPARγ+IRI and premiR-21+IRI groups were significantly lower, while the number of apoptotic cells in the antagomiR-21+IRI group was significantly higher. In addition, significant differences were noted in the AAV9-PPARγ+premiR-21+IRI, AAV9-PPARγ+antagomiR-21 +IRI, and AAV9-PPARγ+IRI groups. Pretreatment with premiR-21 significantly protected the renal tissues against IRI, and the application of antagomiR-21 resulted in poor renal cell apoptosis. Interestingly, the AAV9-PPARγ+IRI and premiR-21+IRI groups showed that PPARγ activation had a better protective effect than activation of miR-21. These results suggest that PPARγ and miR-21 could decrease apoptotic cell death in kidney tissue and that they play two different roles in renal protection (Figure 7).

Immunohistochemistry and Immunocytochemical
Analysis in Kidney. PPARγ and PDCD4 expressions were considered the main marker of this study. Comparison of immunohistochemical staining showed that PPARγ expression in the kidney was significantly increased after the PPARγ overexpressed AAV9 was injected directly into the kidney compared to the sham group mice. IRI induced PPARγ expression, whereas miR-21 did not affect PPARγ expression in mouse kidney tissues (Figure 8(a)).
Similar to the western blotting results, PDCD4 expression was significantly increased in mice subjected to RIRI, and PPARγ and miR-21 overexpression was associated with reduced PDCD4 protein levels in mice subjected to RIRI. In contrast, dual overexpression of PPARγ and miR-21 in mice resulted in lower PDCD4 expression than that of the AAV9-PPARγ+IRI and premiR-21+IRI groups, and the PDCD4 was partially reversed by miR-21 blockade (Figure 8(b)).
To investigate the localization of PPARγ and PDCD4 expression, immunofluorescence analysis was performed on the kidney tissues. As shown in the figure, the perinuclear location in kidney tissues was observed during PPARγ expression. Moreover, its expression decreased after being subjected to IRI and was elevated by transfection with AAV9-PPARγ. PDCD4 was expressed in the cellular matrix of kidney tissues. These results suggest that after the ischemic insult in the kidney tissues, PPARγ expression was

12
Oxidative Medicine and Cellular Longevity    14 Oxidative Medicine and Cellular Longevity downregulated and PDCD4 was elevated. Furthermore, no significant difference was noted in PPARγ by premiR-21 and antagomiR-21 pretreatment, whereas at least a portion of PDCD4 was induced by antagomiR-21 and IRI (Figures 8(c) and 8(d)).

Discussion
The  decreases miR-21 target PDCD4 expression where caspasemediated apoptosis signaling is involved. Moreover, PPARγ and miR-21 protected mice against RIRI in an in vivo experimental model. These results suggest a potential renoprotective mechanism through which PPARγ mediates the miR-21/PDCD4/caspase-3 axis in RIRI.
PPARγ is a nuclear transcription factor that binds to the peroxisome proliferator responsive element (PPRE) as a heterodimer with retinoid X receptor (RXR). Once activated by its agonists, downstream transcription and expression effects are regulated [13]. The activation of PPARγ leads to the amelioration of renal, hepatic, cerebral, myocardial, and other tissues of IRI [14]. This indicates that PPARγ is a potential therapeutic mediator in IRI. Our previous studies mainly focused on the PPARγ agonist pioglitazone, which was used in type 2 diabetes, to protect against RIRI and the underlying molecular mechanisms. In this study, we directly regulated PPARγ expression via plasmids and found that PPARγ overexpression prevented apoptosis by upregulating miR-21, caspase-3, and PDCD4. The antiapoptosis of PPARγ was also reported by Wu et al. [15] who found that PPARγ overexpression by plasmid had a comparable antiapoptotic effect by upregulating Bcl-2 family proteins, but the antiapoptotic effects were abrogated by PPARγ downregulation when PPARγ siRNA was applied. Another study by Jiang et al. [16] investigated the anti-inflammatory effect of PPARγ on cerebral IRI. In their study, vagus nerve stimulation (VNS) treatment enhanced PPARγ expression, diminished the extent of the ischemic infarct, and alleviated neuronal injury in a rat cerebral IR model. Furthermore, the suppression of inflammatory cytokine secretion during the cerebral IRI process is a result of a PPARγ-mediated mechanism as PPARγ silencing exacerbates ischemic neuronal necrosis. As PPARγ accomplishes these antiapoptotic and anti-inflammatory effects without any exogenous ligands, we speculate that endogenous ligands may be involved in PPARγ activation and thus regulate the expression of noncoding RNA such as miR-21 during the IRI procedure. miR-21 is upregulated in renal tubular epithelial cells subjected to H/R and in the kidneys following ischemic injury. Knockdown of miR-21 promoted cellular apoptosis and necrosis, whereas miR-21 overexpression downregulated cell death [10]. We previously found that in a RIRI model, IRI induced significant upregulation of miR-21 and exerted its antiapoptotic properties, which may be due to the suppression of PDCD4 and activation of caspase-3/8 fragments [11]. Our present study illustrated similar renoprotective functions of miR-21, and miR-21 was significantly downregulated in our in vitro H/R model. Combined with our previous research results, we suggest that miR-21 may be downregulated in the initial stage of IRI, and then, due to the self-defense response, it was upregulated, thereby performing protective functions in the serious disorder stage of cell injury. Researchers have found that in restenosis vascular smooth muscle cells, Bcl-2 is involved in miR-21mediated cellular effects and miR-21 overexpression is associated with increased Bcl-2 expression [17]. However, research in breast cancer cells has revealed that miR-21 expression is inversely associated with Bcl-2 expression [18], which is fundamentally different from restenosis vascular smooth muscle cells. The controversial role of miR-21 in tissue injury may be correlated with the injury stage, histological differences, and mechanistic distinctiveness.
PDCD4 is a key factor in apoptosis. PDCD4 can activate caspase-3 and initiate apoptosis [19]. The antiapoptotic effect of miR-21 was partly mediated through its target genes PDCD4, and PDCD4 translational suppression by miR-21 has been demonstrated in the pathobiology of cancer cell proliferation [20,21]. Overexpression of miR-21 reduced PDCD4 promoter activation by directly targeting the 3′-UTR region. Therefore, miR-21 expression was negatively correlated with PDCD4 [22]. These results support the concept that miR-21 functions as a mediator by a mechanism that involves translational repression of PDCD4. Our primary findings demonstrated that upregulation of PPARγ enhanced miR-21 expression, thus inhibiting PDCD4 expression, improving cell viability, and reducing apoptosis in RIRI. PDCD4 may activate caspase-3 and promote cell apoptosis. In contrast, another study suggested that inactivation of miR-21 stimulated PDCD4 and induced pulmonary artery endothelial apoptosis through caspase-3 activation. This phenomenon was abrogated by miR-21 mimic transfection, and the PDCD4/caspase-3 axis was silenced, thus preventing apoptosis [23]. Collectively, our findings demonstrated that the underlying miR-21/PDCD4/caspase-3 axis on activation drives apoptosis both in vitro and in vivo. From another perspective, the underlying miR-21/PDCD4/ caspase-3 pathway may participate in human IRI pathogenesis. Our findings underscore the potential utility of future clinical investigations targeting the miR-21/PDCD4/caspase-3 axis. In a study on pulmonary arterial hypertension, Green et al. [24] found that PPARγ activation can reduce the proliferation of vascular smooth muscle cells and affect disease progression by regulating miR-21 and affecting PDCD4 expression. In conclusion, combined with these results, intrinsic regulation may also exist between PPARγ and miR-21 during RIRI.
As a transcription factor, PPARγ is generally considered to be involved in the regulation of one or more classes of functionally related protein-coding genes, and PPARγ has been identified as a regulator of lipid metabolism and fibrosis [25]. Most miRNAs are transcribed from specific genes with specific promoters located throughout the genome. miRNAs have been confirmed to participate in the pivotal biological processes of posttranscriptional gene regulation [26]. Since transcription factors and miRNAs function as transcription and translation factors, little is known about their relationship. Fortunately, an increasing number of studies have begun to focus on elaborating the molecular mechanisms involved in pathophysiological procedures. In 2015, Dharap et al. used the PPARγ synthetic ligand rosiglitazone in adult rats before miRNA profiling was conducted using microarrays, and 28 miRNAs were found to be altered significantly after treatment with rosiglitazone [27]. A study conducted by Winkler et al. [28] demonstrated that PPARγ directly regulates a class of miRNAs that are functionally associated with antifibrotic properties. In their study, PPARγ was described as a key regulator in antifibrotic miRNA 16 Oxidative Medicine and Cellular Longevity regulation and miRNAs targeting key fibrosis-associated genes. Hence, the formation of an intricate coherent feedforward loop among PPARγ, miRNAs, and the corresponding target gene plays a significant role in fibrosis regulation. In contrast, PPARγ and miRNAs may have diverse relationships other than the modulatory role of PPARγ in miRNAs. For example, PPARγ was identified as a miR-130b direct target in colorectal cancers [29], and miR-130b was also identified as an independent prognostic biomarker in glioma patients by targeting PPARγ [30]. In addition to miR-130b, miR-27a [31], miR-128 [32], and miR-19b [33] were proved to act as upstream mediators targeting PPARγ. miRNAs may have potential promoter regions in the PPREs. The miR-145 and miR-329 expression levels were significantly modulated by PPARγ expression vector transfection and were reversed by point mutations of PPREs in their promoters. Furthermore, transfection with miR-329 mimic and miR-145 mimic was demonstrated to activate PPARγ, suggesting underlying binding sites for miRNAs in the PPARγ promoter [27]. Mechanistically, miR-21 is regulated by the transcription factor PPARγ. Our study highlights the role of the master regulator of transcription factor PPARγ in miR-21 regulation. However, the regulatory function needs to be comprehensively considered in various pathologies, tissues, and biological procedures before the mechanism whereby PPARγ activation prevents RIRI can be elucidated.

Conclusion
In this study, we showed that both PPARγ and miR-21 had protective effects on RIRI to varying degrees, overexpression of PPARγ or miR-21 could mitigate the cell damage and cell apoptosis through regulating the apoptotic proteins, and there was an interaction between PPARγ and miR-21. Our findings underscore the potential utility of future clinical investigations, whereby PPARγ activation regulates the underlying miR-21/PDCD4 pathway, which may participate in human IRI pathogenesis.

Data Availability
The data that support the findings of this study are available from the corresponding author, upon reasonable request.

Conflicts of Interest
No conflicts of interest exist in the submission of this manuscript.

Authors' Contributions
This study was designed by HH. RH, CZ, XW, XZ, ZX, TL, BG, and ZW conducted the study. RH, CZ, and XW analyzed and interpreted the data. RH drafted the manuscript and was responsible for revising it. Ruizhen Huang, Cong Zou, and Chiyu Zhang contributed equally to this work. The manuscript has been approved by all authors for publication.